Sprycel 140 mg, Filmtabletten - 30 Tablette(n) Swissmedic Key 57658014 Registration Holder Bristol-Myers Squibb SA Name Sprycel 140 mg, Filmtabletten Date of registration 02.02.2007 Introduction of Sequence 22.07.2011 ATC-Classification Dasatinib (L01EA02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 30 Tablette(n) Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680576580149 Medication Code Synthetika Pharmacode Disponibility
Composition dasatinibum 140 mg ut dasatinibum monohydricum, lactosum monohydricum 189 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 1.57 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dasatinib 140 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Hydroxypropylcellulosum Hypromellosum Überzug Lactose Monohydrate 189 mg Macrogol 400 Magnesii Stearas Pro Compresso Obducto
Source Data was imported : 06.08.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
